Feasibility of long-term patient self-reporting of toxicities from home via the internet during routine chemotherapy Journal Article

Authors: Judson, T. J.; Bennett, A. V.; Rogak, L. J.; Sit, L.; Barz, A.; Kris, M. G.; Hudis, C. A.; Scher, H. I.; Sabbatini, P.; Schrag, D.; Basch, E.
Article Title: Feasibility of long-term patient self-reporting of toxicities from home via the internet during routine chemotherapy
Abstract: Purpose Patient-reported outcomes are increasingly used in routine outpatient cancer care to guide clinical decisions and enhance communication. Prior evidence suggests good patient compliance with reporting at scheduled clinic visits, but there is limited evidence about compliance with long-term longitudinal reporting between visits. Patients and Methods Patients receiving chemotherapy for lung, gynecologic, genitourinary, or breast cancer at a tertiary cancer center, with access to a home computer and prior e-mail experience, were asked to self-report seven symptomatic toxicities via the Web between visits. E-mail reminders were sent to participants weekly; patient-reported high-grade toxicities triggered e-mail alerts to nurses; printed reports were provided to oncologists at visits. A priori threshold criteria were set to determine if this data collection approach merited further development based on monthly (>= 75% participants reporting at least once per month on average) and weekly compliance rates (60% at least once per week). Results Between September 2006 and November 2010, 286 patients were enrolled (64% were women; 88% were white; median age, 58 years). Mean follow-up was 34 weeks (range, 2 to 214). On average, monthly compliance was 83%, and weekly compliance was 62%, without attrition until the month before death. Greater compliance was associated with older age and higher education but not with performance status. Compliance was greatest during the initial 12 weeks. Symptomatic illness and technical problems were rarely barriers to compliance. Conclusion Monthly compliance with home Web reporting was high, but weekly compliance was lower, warranting strategies to enhance compliance in routine care settings. (C) 2013 by American Society of Clinical Oncology
Keywords: myelofibrosis; communication; clinical-trials; national-cancer-institute; quality-of-life; randomized controlled-trial; care; outcomes assessment; ruxolitinib; management-system asyms(c)
Journal Title: Journal of Clinical Oncology
Volume: 31
Issue: 20
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2013-07-10
Start Page: 2580
End Page: 2585
Language: English
ACCESSION: WOS:000330537800027
DOI: 10.1200/jco.2012.47.6804
PMCID: PMC3699724
PUBMED: 23733753
Notes: Article -- Source: Wos
Altmetric Score
MSK Authors
  1. Clifford Hudis
    840 Hudis
  2. Ethan Martin Basch
    156 Basch
  3. Paul J Sabbatini
    199 Sabbatini
  4. Allison Barz
    11 Barz
  5. Antonia Bennett
    17 Bennett
  6. Howard Scher
    817 Scher
  7. Mark Kris
    597 Kris
  8. Laura S Sit
    21 Sit
  9. Lauren Jayne Rogak
    44 Rogak